Positron emission tomographic imaging in stroke: Cross-sectional and follow-up assessment of amyloid in ischemic stroke

Stroke

Volumn 47, Issue 1, 2016, Pages 113-119

  Sahathevan, Ramesh ^a,b,c   Linden, Thomas ^a,d   Villemagne, Victor L ^b,e   Churilov, Leonid ^a,b   Ly, John V ^a,b   Rowe, Christopher ^b,e   Donnan, Geoffrey ^a,b   Brodtmann, Amy ^a,b  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e AUSTIN HOSPITAL   (Australia)

Author keywords

Alzheimer disease; follow up studies; positron emission tomography; risk factors

Indexed keywords

AMYLOID BETA PROTEIN; GADOLINIUM; PITTSBURGH COMPOUND B;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN REGION; CAROTID ARTERY OBSTRUCTION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; FOLLOW UP; HEMISPHERE; HUMAN; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STROKE PATIENT; WHITE MATTER LESION; CEREBROVASCULAR ACCIDENT; DIAGNOSTIC IMAGING; METABOLISM; MIDDLE AGED; RISK FACTOR; TRENDS;

AGED; AMYLOID BETA-PEPTIDES; BRAIN ISCHEMIA; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RISK FACTORS; STROKE;

EID: 84952631267     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.010528     Document Type: Article

References (32)

1. Pendlebury ST, Rothwell PM., Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-Analysis. Lancet Neurol 2009 8 1006 1018. doi: 10.1016/S1474-4422(09)70236-4
2. Sahathevan R, Brodtmann A, Donnan GA., Dementia, stroke, and vascular risk factors; a review. Int J Stroke 2012 7 61 73. doi: 10.1111/j.1747-4949.2011.00731.x
3. Jellinger KA, Attems J., Neuropathological evaluation of mixed dementia. J Neurol Sci 2007 257 80 87. doi: 10.1016/j.jns.2007.01.045
4. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann Neurol 2004 55 306 319. doi: 10.1002/ana.20009
5. Rowe CC, Villemagne VL., Brain amyloid imaging. J Nucl Med 2011 52 1733 1740. doi: 10.2967/jnumed.110.076315
6. Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, Imaging beta-Amyloid burden in aging and dementia. Neurology 2007 68 1718 1725. doi: 10.1212/01.wnl.0000261919.22630.ea
7. Villemagne VL, Pike KE, Chételat G, Ellis KA, Mulligan RS, Bourgeat P, Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease. Ann Neurol 2011 69 181 192. doi: 10.1002/ana.22248
8. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011 7 263 269. doi: 10.1016/j.jalz.2011.03.005
9. Popa-Wagner A, Schröder E, Walker LC, Kessler C., beta-Amyloid precursor protein and ss-Amyloid peptide immunoreactivity in the rat brain after middle cerebral artery occlusion: effect of age. Stroke 1998 29 2196 2202
10. Aho L, Jolkkonen J, Alafuzoff I., Beta-Amyloid aggregation in human brains with cerebrovascular lesions. Stroke 2006 37 2940 2945. doi: 10.1161/01.STR.0000248777.44128.93
11. Lee PH, Bang OY, Hwang EM, Lee JS, Joo US, Mook-Jung I, Circulating beta amyloid protein is elevated in patients with acute ischemic stroke. J Neural Transm 2005 112 1371 1379. doi: 10.1007/s00702-004-0274-0
12. Marchant NL, Reed BR, DeCarli CS, Madison CM, Weiner MW, Chui HC, Cerebrovascular disease, β-Amyloid, and cognition in aging. Neurobiol Aging 2012 33 1006.e25 1006.e36. doi: 10.1016/j.neurobiolaging.2011.10.001
13. de la Torre JC., The vascular hypothesis of Alzheimer's disease: bench to bedside and beyond. Neurodegener Dis 2010 7 116 121. doi: 10.1159/000285520
14. de la Torre JC., Preface: Physiopathology of vascular risk factors in Alzheimer's Disease. J Alzheimers Dis 2012 32 517 518. doi: 10.3233/JAD-2012-120830
15. Tolppanen AM, Solomon A, Soininen H, Kivipelto M., Midlife vascular risk factors and Alzheimer's disease: evidence from epidemiological studies. J Alzhceimers Dis 2012 32 531 540. doi: 10.3233/JAD-2012-120802
16. Hachinski V., Stroke and Alzheimer disease: fellow travelers or partners in crime? Arch Neurol 2011 68 797 798. doi: 10.1001/archneurol.2011.118
17. Nettiksimmons J, Beckett L, Schwarz C, Carmichael O, Fletcher E, Decarli C., Subgroup of ADNI normal controls characterized by atrophy and cognitive decline associated with vascular damage. Psychol Aging 2013 28 191 201. doi: 10.1037/a0031063
18. Liu W, Wong A, Law AC, Mok VC., Cerebrovascular disease, amyloid plaques, and dementia. Stroke 2015 46 1402 1407. doi: 10.1161/STROKEAHA.114.006571
19. Ngandu T, Lehtisalo J, Solomon A, Levälahti E, Ahtiluoto S, Antikainen R, A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 2015 385 2255 2263. doi: 10.1016/S0140-6736(15)60461-5
20. Ly JV, Rowe CC, Villemagne VL, Zavala JA, Ma H, Sahathevan R, Subacute ischemic stroke is associated with focal 11C PiB positron emission tomography retention but not with global neocortical Aβ deposition. Stroke 2012 43 1341 1346. doi: 10.1161/STROKEAHA.111.636266
21. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C., A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project-1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 1990 53 16 22
22. Ly JV, Rowe CC, Villemagne VL, Zavala JA, Ma H, O'Keefe G, Cerebral β-Amyloid detected by Pittsburgh compound B positron emission topography predisposes to recombinant tissue plasminogen activator-related hemorrhage. Ann Neurol 2010 68 959 962. doi: 10.1002/ana.22072
23. Fiorelli M, Bastianello S, von Kummer R, del Zoppo GJ, Larrue V, Lesaffre E, Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 1999 30 2280 2284
24. Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging 2010 31 1275 1283. doi: 10.1016/j.neurobiolaging.2010.04.007
25. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA., MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987 149 351 356. doi: 10.2214/ajr.149.2.351
26. Huang KL, Lin KJ, Ho MY, Chang YJ, Chang CH, Wey SP, Amyloid deposition after cerebral hypoperfusion: evidenced on [(18)F]AV-45 positron emission tomography. J Neurol Sci 2012 319 124 129. doi: 10.1016/j.jns.2012.04.014
27. Provenzano FA, Muraskin J, Tosto G, Narkhede A, Wasserman BT, Griffith EY, Alzheimer's Disease Neuroimaging Initiative White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease? JAMA Neurol 2013 70 455 461. doi: 10.1001/jamaneurol.2013.1321
28. Park JH, Seo SW, Kim C, Kim SH, Kim GH, Kim ST, Effects of cerebrovascular disease and amyloid beta burden on cognition in subjects with subcortical vascular cognitive impairment. Neurobiol Aging 2014 35 254 260. doi: 10.1016/j.neurobiolaging.2013.06.026
29. Zlokovic BV., The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008 57 178 201. doi: 10.1016/j.neuron.2008.01.003
30. Pike VW., PET radiotracers: crossing the blood-brain barrier and surviving metabolism. Trends Pharmacol Sci 2009 30 431 440. doi: 10.1016/j.tips.2009.05.005
31. Garcia-Alloza M, Gregory J, Kuchibhotla KV, Fine S, Wei Y, Ayata C, Cerebrovascular lesions induce transient β-Amyloid deposition. Brain 2011 134 Pt 12 3697 3707. doi: 10.1093/brain/awr300
32. Mok V, Leung EY, Chu W, Chen S, Wong A, Xiong Y, Pittsburgh compound B binding in poststroke dementia. J Neurol Sci 2010 290 135 137. doi: 10.1016/j.jns.2009.12.014